Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping

Clinical trial NCT06881017 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06881017
Sponsor: China Medical University, China
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Cancer HER2 + Gastric Cancer CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction PD-L1 Positive

Start date: 2025-05-01
Primary completion: 2029-08-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.